Benign neoplasm of ascending colon
ICD-10 D12.2 is a billable code used to indicate a diagnosis of benign neoplasm of ascending colon.
A benign neoplasm of the ascending colon refers to a non-cancerous tumor that arises in the ascending segment of the large intestine. These neoplasms can include adenomas, hyperplastic polyps, and other types of growths that do not exhibit malignant characteristics. While benign, these neoplasms can still pose clinical concerns, particularly if they lead to obstruction, bleeding, or other gastrointestinal symptoms. Surveillance is often recommended, as certain types of benign neoplasms, particularly adenomatous polyps, have the potential to progress to colorectal cancer over time. Regular colonoscopic evaluations are essential for monitoring these lesions, especially in patients with a history of polyps or familial predisposition to colorectal cancer. The management of benign neoplasms typically involves surveillance and, in some cases, surgical intervention if the neoplasm is symptomatic or shows signs of dysplasia. Accurate coding of D12.2 is crucial for appropriate patient management and insurance reimbursement.
Detailed reports of colonoscopy findings, biopsy results, and follow-up plans.
Patients presenting with abdominal pain, rectal bleeding, or incidental findings during screening colonoscopy.
Documentation should clearly indicate the type of neoplasm and any associated symptoms or interventions.
Operative reports detailing the excision of neoplasms, pathology reports, and post-operative follow-up.
Patients undergoing surgical resection of benign neoplasms due to obstruction or symptomatic presentation.
Ensure that the surgical indication and pathology findings are well-documented to support coding.
Used for surveillance of benign neoplasms in the ascending colon.
Document findings, any biopsies taken, and follow-up recommendations.
Gastroenterologists should ensure that the indication for the procedure is clearly stated.
Coding D12.2 accurately reflects the presence of a benign neoplasm in the ascending colon, which is crucial for appropriate management and surveillance. It helps in tracking the patient's condition and ensuring that necessary follow-up care is provided.
